CROWN Congress, Philadelphia- January 23-25, 2018

CROWN provides a comprehensive education on the latest strategies, trends, tools and technologies for optimizing clinical trials and enables you to make the connections necessary to streamline operations and advance. This multi-tracked event is built around topics such as clinical innovation, risk management, outsourcing strategies, operational metrics, risk-based monitoring, relationship building, patient engagement, site performance and clinical data optimization.

SCOPE Summit for Clinical Ops Executives, Florida – February 12-15, 2018

The 9th Annual SCOPE Summit, taking place February 13-15, 2018 in Orlando, FL, will offer three stimulating days of in-depth discussions in 18 different conferences, 3 plenary keynote sessions, and the ever-popular interactive breakout discussions focused on advances and innovative solutions in all aspects of clinical trial planning.

Outsourcing in Clinical Trials West Coast – February 21-22, 2018

Developing specific outsourcing strategies to meet the demands of your company’s resources and capabilities. Arena International’s flagship Outsourcing in Clinical Trials West Coast conference returns to the Bay Area for its 10th year in February 2018. With 3 new tracks on clinical innovation, data-driven approaches and early phase development, this year’s conference is guaranteed to be packed with cutting-edge content.


Outsourcing in Clinical Trials Europe – May 15-16, 2018

Outsourcing in Clinical Trials Europe came to Barcelona for the 7th annual event and brought together an audience of over 450 professionals from throughout Europe including Abbott, AstraZeneca, Sanofi , Novartis, and Boehringer Ingelheim.


DIA, Boston- June 24-28, 2018

Designed to drive insights into action by connecting key policy discussions to real-world knowledge that you need to do your job every day, your attendance will accelerate your growth and your organization’s performance in the development ecosystem. Sessions will include distinguished speakers and expert panelists from regulatory, industry, patient advocacy, and academia